In contemporary cancer care, circulating tumor cells (CTCs) are emerging not just as markers of disease activity, but as active contributors to personalized management strategies. For patients with metastatic colorectal cancer (mCRC), the enumeration and molecular analysis of CTCs offer insights into prognosis, therapy monitoring, and customized care planning.
Chelation therapy is a clinical approach that uses chelating agents—compounds capable of binding to heavy metals and minerals in the body—to support their removal. These agents form complexes with substances such as lead, mercury, arsenic, or cadmium, which are then excreted through the urine. Though primarily used in cases of heavy metal toxicity, chelation therapy is being explored for its potential supportive role in a variety of chronic health conditions.
Exploring the Auxiliary Role of CTC Detection in Observing Bone Metastasis in Cancer Exploring the Auxiliary Role of CTC Detection in Observing Bone Metastasis in
Malnutrition is a common yet often overlooked concern in cancer care. Even when patients appear to be consuming adequate calories, they may continue to lose weight, experience fatigue, and suffer from a weakened immune system. A major underlying factor in these issues is metabolic imbalance.
Ivermectin, a well-known anti-parasitic drug, has recently garnered attention for its potential role in cancer adjunctive therapy. While its primary use is for treating parasitic infections, studies suggest that Ivermectin might play unexpected roles in inhibiting cancer cell growth, enhancing treatment efficacy, and supporting the immune system.
In cancer care, nutrition plays a crucial role. However, despite supplementing with various nutrients, many patients find little improvement in their condition. One commonly overlooked reason is malabsorption—the body’s inability to effectively absorb nutrients from food or supplements.
In the realm of cancer care, Poly-MVA, a nutritional supplement, is gaining attention for its potential role in supporting cellular energy metabolism and antioxidant systems. This unique formula combines Alpha-Lipoic Acid, B vitamins, minerals, and the Lipoic Acid Palladium Complex (LAPd), which are designed to assist the body’s recovery and healing processes during or after cancer treatment.
In recent years, the role of the gut microbiome in cancer care has gained increasing attention. Scientific studies have shown that the balance of intestinal bacteria plays a significant role in modulating the immune system, influencing not only cancer progression but also responses to treatment and overall recovery. Among various metabolites produced by gut bacteria, butyrate, a short-chain fatty acid (SCFA), stands out for its ability to support immune regulation and reduce inflammation in a gentle, natural way.
For many individuals recovering from cancer, restoring the balance of daily routines and overall physical health is a critical part of the healing process. Among the many aspects of recovery, “sleep quality” and “circadian rhythm balance” are common challenges faced by patients. In recent years, the potential of Melatonin in regulating these factors has garnered increasing attention from researchers and users alike.
In cancer care, the use of traditional herbs and plants has gained increasing attention. Pau d’Arco, a plant native to South America, has been used by indigenous people for the treatment of various health issues for centuries. Recently, with a renewed interest in natural therapies, Pau d’Arco has started to enter the field of cancer care research. Its unique antioxidant, anti-inflammatory, and immune-regulating properties have garnered widespread interest. This article explores the potential applications of Pau d’Arco in cancer care and presents related research findings.